P. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy

US9765321B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9765321-B2
Application numberUS-201414323678-A
CountryUS
Kind codeB2
Filing dateJul 3, 2014
Priority dateOct 10, 2006
Publication dateSep 19, 2017
Grant dateSep 19, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel promoters which are derived from P. pastoris pastoris which are inducible or repressible under specific growth conditions are provided. These promoters are useful for regulating the expression of a desired structural gene, e.g., a mammalian polypeptide. Particularly preferred is the use of these novel promoters to regulate gene expression in polyploidal yeast such as diploidal P. pastoris produced by mating or spheroplast fusion.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated nucleic acid sequence containing an enolase (ENOI) promoter derived from the P. pastoris ENOI gene having the nucleic acid sequence contained in SEQ ID NO:22, which when operably linked to a structural gene renders the expression of the gene methanol repressive, and which is operably linked to a heterologous structural gene. 2. The isolated nucleic acid sequence of claim 1 wherein said structural gene encodes a non-yeast protein. 3. The isolated nucleic acid sequence of claim 2 wherein the structural gene is a mammalian gene. 4. The isolated nucleic acid sequence of claim 2 wherein the structural gene encodes an antibody polypeptide. 5. A plasmid containing the isolated nucleic acid of claim 1 . 6. A plasmid containing the isolated nucleic acid of claim 2 . 7. A plasmid containing the isolated nucleic acid of claim 3 . 8. A plasmid containing the isolated nucleic acid of claim 4 . 9. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is other than ENO1. 10. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is a mammalian structural gene. 11. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is a sequence encoding an antibody polypeptide. 12. A yeast cell according to claim 9 which is a P. pastoris, Candida, Saccharomyces, Yarrowia, Kluyveromyces, Hansenula , or Schizosaccharomyces yeast cell. 13. The yeast cell of claim 9 which is a P. pastoris yeast cell. 14. The yeast cell of claim 12 which is polyploid. 15. The yeast cell of claim 13 which is polyploid. 16. A method of using a yeast cell according to claim 9 to produce the protein encoded by said structural gene under the regulatory control of said ENO1 promoter. 17. The method of claim 16 wherein the protein is a mammalian protein. 18. The method of claim 17 wherein the mammalian protein is an antibody, cytokine or growth factor.

Assignees

Inventors

Classifications

  • using catalysts, e.g. selective catalysts · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • for yeasts · CPC title

  • Phosphopyruvate hydratase (4.2.1.11), i.e. enolase · CPC title

  • against the T-cell receptor (TcR)-CD3 complex · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9765321B2 cover?
Novel promoters which are derived from P. pastoris pastoris which are inducible or repressible under specific growth conditions are provided. These promoters are useful for regulating the expression of a desired structural gene, e.g., a mammalian polypeptide. Particularly preferred is the use of these novel promoters to regulate gene expression in polyploidal yeast such as diploidal P. pasto…
Who is the assignee on this patent?
Alderbio Holdings Llc, Alderbio Holdings Llc
What technology area does this patent fall under?
Primary CPC classification C12N9/88. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).